Home›Search›Pharmaceutical Science Advances

Pharmaceutical Science Advances

Elsevier B.V. · Netherlands · Est. 2022

ISSN2773-2169

SJR Q2✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ Scopus Q2+18

✓ DOAJ Verified+15

Total43

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.379

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Works

100

Total Citations

690

2yr Mean Citedness

4.47

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

Pharmaceutical Science Advances publishes research on drug discovery, development, and delivery. This includes the investigation of novel therapeutic agents, such as tyrosine kinase inhibitors for cancer, sphingosine kinase inhibitors with broad applications, and natural product derivatives for various conditions. The journal also covers advancements in drug delivery systems, including bio-based nanomaterials, nanocarriers, and radiopharmaceutical carriers, as well as the application of artificial intelligence and computational methods in drug design. Research on traditional Chinese medicine and its active components is also featured.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 50% in field

General Information

Country / RegionNetherlands

Primary LanguageEnglish

1st Year Published2022

Annual Volume~ 29 articles / year

StatusActive (last: 2026)

Total Publications100

Publisher OrgElsevier BV

OA Since2022

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~13 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Elsevier B.V.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2773-2169

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmaceutical ScienceQ2

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q2

PharmacologyQ3

Subject Classification

Scopus Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)PharmacologyPharmaceutical Science

Research Topics (OpenAlex)

Nanoparticle-Based Drug DeliveryDrug Solubulity and Delivery SystemsComputational Drug Discovery MethodsAdvanced Drug Delivery SystemsAutophagy in Disease and TherapyMicrobial Natural Products and BiosynthesisDrug Transport and Resistance MechanismsCancer, Hypoxia, and MetabolismHER2/EGFR in Cancer ResearchNanoplatforms for cancer theranostics